Hamostaseologie. 2017;37(2):117-126. doi: 10.5482/HAMO-16-09-0033. Epub 2017 Dec 28.
Haemophilia care in Germany has achieved a high level and enables the majority of patients to lead a largely normal life. The Bluter Betreuung Bayern e.V. (BBB) aims to improve health care and support for haemophilia patients. A questionnaire has been developed by BBB representatives to evaluate unmet medical needs from the patient perspective. It was sent to 290 haemophilia patients and/or their parents in Bavaria in November 2015. The response rate was 51.4 %: 66 children aged < 15 years (66.7 % severe), 30 patients 15-24 years (66.7 % severe), 26 patients 25-44 years (80.8 % severe), 24 patients > 44 years (95.8 % severe). Prophylactic therapy in patients with severe haemophilia aged < 25 and ≥ 25 years is given "always" in ≥ 80 % and > 60 %, respectively. Substitution therapy is mostly uncomplicated. Satisfaction with medical care is high. Chronic pain is a problem with increasing age. Patients aged 25-44 years worry least regarding future health, safety and availability of factor products, patients > 44 years most. Overall, 80-100 % of the patients from all age groups are interested in information on the current state of science. Offers of the BBB for psychosocial support in addition to the medical care seem to be helpful and needed in all age groups.
德国的血友病治疗已达到较高水平,使大多数患者能够过上基本正常的生活。巴伐利亚血液关怀协会(BBB)旨在改善血友病患者的医疗保健和支持。BBB 代表制定了一份问卷,从患者角度评估未满足的医疗需求。该问卷于 2015 年 11 月发送给巴伐利亚州的 290 名血友病患者及其父母。回复率为 51.4%:66 名年龄<15 岁的儿童(66.7%为重度),30 名 15-24 岁的患者(66.7%为重度),26 名 25-44 岁的患者(80.8%为重度),24 名>44 岁的患者(95.8%为重度)。<25 岁和≥25 岁的重度血友病患者预防性治疗的接受率分别为“总是”(≥80%)和“经常”(>60%)。替代疗法大多没有并发症。对医疗护理的满意度很高。慢性疼痛随着年龄的增长而成为一个问题。25-44 岁的患者对未来的健康、安全和因子产品的可及性最不担忧,44 岁以上的患者最担忧。总体而言,所有年龄组的患者中有 80-100%对当前科学状况的信息感兴趣。BBB 提供的除医疗保健以外的心理社会支持的提议在所有年龄组似乎都是有帮助和需要的。